Sevuparin

N/A

Report date: 2024/12/18 14:11:51

Base Information

Drug NameSevuparin
Drug Alias NameLow anticoagulant heparinSevuparin sodiumDF-02
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionCell adhesion molecules inhibitorsGlycosaminoglycan stimulantsHeparin agonists
TargetsHeparinCell adhesion moleculesGlycosaminoglycan
Therapy Area/IndicationsAnemia, Sickle CellMalaria, Falciparum
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryThailandNetherlandsSaudi Arabia +[8] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDilafor Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesModus Therapeutics Ab
Active IndicationsN/A
Inactive IndicationsAnemia, Sickle CellMalaria, Falciparum

Other Information

ATC CodeN/A
Related LinksN/A